Abstract
HORIZON (OP-106): Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma with High-Risk Cytogenetics-Subgroup Analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have